Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Exchange Rate Effect: 2014-2022

Historic Exchange Rate Effect for Protagonist Therapeutics (PTGX) over the last 9 years, with Dec 2022 value amounting to -$90,000.

  • Protagonist Therapeutics' Exchange Rate Effect rose 240.91% to $75,000 in Q4 2022 from the same period last year, while for Dec 2022 it was -$90,000, marking a year-over-year increase of 28.57%. This contributed to the annual value of -$90,000 for FY2022, which is 28.57% up from last year.
  • Protagonist Therapeutics' Exchange Rate Effect amounted to -$90,000 in FY2022, which was up 28.57% from -$126,000 recorded in FY2021.
  • In the past 5 years, Protagonist Therapeutics' Exchange Rate Effect ranged from a high of $175,000 in FY2020 and a low of -$177,000 during FY2018.
  • Its 3-year average for Exchange Rate Effect is -$13,667, with a median of -$90,000 in 2022.
  • In the last 5 years, Protagonist Therapeutics' Exchange Rate Effect slumped by 221.23% in 2018 and then spiked by 773.08% in 2020.
  • Protagonist Therapeutics' Exchange Rate Effect (Yearly) stood at -$177,000 in 2018, then soared by 85.31% to -$26,000 in 2019, then surged by 773.08% to $175,000 in 2020, then slumped by 172.00% to -$126,000 in 2021, then grew by 28.57% to -$90,000 in 2022.